Proteome Sciences (PI2) AI Stock Analysis

Proteome Sciences

(Frankfurt:PI2)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Specialized Proteomics PlatformThe company has a specialized analytical platform centered on proteomics, mass spectrometry, and bioinformatics. These capabilities are directly relevant to drug discovery and biomedical research, providing a focused basis for serving technically demanding customers over the medium term.

Negative Factors

Falling Revenue and Persistent LossesRevenue contraction alongside negative gross profit and substantial operating and net losses indicates weak cost absorption and limited earnings stability. Persistent losses reduce internally generated funding for research, commercial development, and the investments needed to rebuild growth.

Proteome Sciences (PI2) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 5.10M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -2.0
Beta (1Y): -4.54
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 32
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Specialties

Proteome Sciences Business Overview & Revenue Model

Company Description

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standa...

Proteome Sciences Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:PI2 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:GDR	49Neutral	GBP 15.65M	-0.89	-1044.57%	―	65.60%	74.84%
GB:CLBX	48Neutral	GBP 6.82M	-0.49	-104.73%	―	-56.10%	41.10%
GB:VRCI	44Neutral	GBP 15.32M	-0.60	-127.57%	―	77.87%	84.36%
GB:OPTI	41Neutral	GBP 5.99M	-1.40	-77.85%	―	11.90%	-2864.29%
GB:GENI	39Underperform	GBP 4.97M	-0.49	-481.34%	―	-10.81%	42.67%

* Healthcare Sector Average

Performance Comparison

DE:PI2 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:PI2	Proteome Sciences	0.03	0.02	120.00%
GB:CLBX	ANGLE plc	0.60	-1.95	-76.47%
GB:GDR	Genedrive plc	0.97	0.01	1.25%
GB:OPTI	OptiBiotix Health	5.80	-2.20	-27.50%
GB:VRCI	Verici Dx Plc	0.23	-0.45	-65.93%
GB:GENI	GENinCode UK Ltd.	0.66	-2.24	-77.24%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Proteome Sciences AI Stock Analysis